DBDavid BackPhDVideoHIVRio de Janeiro HIV Clinical Forum 2018DDIs, INSTIs, TB and hepatitis | David Back, PhDView Video
RDRicardo DiazMDVideoHIVRio de Janeiro HIV Clinical Forum 2018Transmitted resistance to ARVs and its impact on initial therapy | Ricardo Diaz, MDView Video
CBCharles BoucherMD, PhDVideoHIVRio de Janeiro HIV Clinical Forum 2018Resistance to Integrase Inhibitors | Charles Boucher, MD, PhDView Video
VideoHIVMexican HIV Clinical Forum 2018Integrase Inhibitors in Women and Pediatrics | Alberto Chaparro-Sánchez, MDView Video
VideoHIVMexican HIV Clinical Forum 2018Optimal use of Integrase Inhibitors in Routine Patient Care in Mexico | Luis Soto-Ramirez, MDView Video
VideoHIVMexican HIV Clinical Forum 2018Clinical case presentation | Santiago Pérez Patrigeon, PhDView Video
VideoHIVMexican HIV Clinical Forum 2018Pharmacological Characteristics and Delivery Options of the Integrase Inhibitors | Courtney Fletcher, PharmDView Video
PTPablo TebasMDVideoHIVMexican HIV Clinical Forum 2018Clinical Update on Integrase Inhibitors: Recent Data | Pablo Tebas, MDView Video
VideoHIVMexican HIV Clinical Forum 2018HIV integrase Inhibitors: A novel mechanisms of action | Francisco Flores Murrieta, PhDView Video
VideoHIVArgentina HIV Clinical Forum 2018Pharmacology and new modes of delivery | David Back, PhDView Video
